FibriCheck

Last updated on
FibriCheck

Visit website

NHS problem

As cardiovascular disease is the leading cause of death worldwide and hospital wards are under immense pressure, there is a need for detection and monitoring of cardiovascular diseases that is both time and cost-efficient. The current approach proves to be both time-consuming and financially burdensome. Moreover, patients frequently have to endure prolonged wait times due to insufficient hardware availability, exacerbating health risks during the wait time due to potential complications. Addressing these challenges is imperative to safeguard patient well-being and optimise healthcare delivery.

The solution

We’re on a mission to reduce the burden of cardiovascular diseases using a device-agnostic approach.

FibriCheck is a medically certified (MHRA / CE (class IIa) and FDA-approved) digital health solution that utilises commoditized electronics such as smartphones and wearables. FibriCheck has been extensively clinically validated in +70 peer-reviewed publications (including RCT) and proven to make clinical pathways more efficient. We offer accurate remote heart rate and heart rhythm measurements and empower users to follow up on their symptoms, blood pressure, and weight. With our technology, heart health conditions such as atrial fibrillation can be detected early on and monitored pre-and post-intervention. All results are immediately available through our FibriCheck Portal for easy follow-up by healthcare providers.

As our technology offers remote real-time insights into heart health without requiring any additional hardware, we can make a significant impact on the average length of hospital stay, reduce costs, address workforce challenges, and reduce the backlog of patients waiting for care. FibriCheck can be used as a stand-alone app or can be integrated in various ways according to your needs. In the UK, FibriCheck is already implemented across 20+ pathways in the NHS and used by over 300,000 patients.

Impact

Proven cost-saving in post-intervention pathways: The Essex Cardiothoracic Centre integrated FibriCheck in a digitally enabled pathway to detect AF recurrence after ablation. The use of our technology made it possible to avoid 147 ECGs and 55 seven-day Holters, which translates to an estimated net savings of £19,040 and 73.5 outpatient clinic hours. This project was presented at the Heart Rhythm Society experience and won a global cardiovascular award (Link to publication).

Reducing length of stay and discharge: At the West Middlesex Hospital and Chelsea & Westminster Hospital, the integration of FibriCheck allows for early discharge of diagnosed atrial fibrillation patients. We successfully cut the average length of stay by 4 days per patient, leading to approximately £1.000 direct cost savings per patient (Link to publication).

Reducing the backlog of patients waiting for care: Several of our projects in the UK demonstrate a significant impact on patient wait lists. At the Barking, Havering and Redbridge University Hospital for example, our technology is being used in an effective pathway for detecting, diagnosing, and managing atrial fibrillation in at-risk patients. This allows for increased detection rates (4.9%), which after ECG confirmation can lead to prompt treatment within 48 to 72 hours (Link to publication).

Efficient cross-condition management: Health Care First is using FibriCheck to remotely identify atrial fibrillation in high-risk chronic obstructive pulmonary disease patients who didn’t undergo ECG examinations in the past 2 years due to reduced capacity and pressure on the system. With FibriCheck, AF was identified in 5.6% of patients, which was later confirmed by ECG (Link to publication).

Time savings for healthcare professionals: In our TeleCheck-AF project, over 8.000 patients across more than 40 European centres were onboarded seamlessly and healthcare providers could easily access patient measurements through the FibriCheck infrastructure from day one. This led to a 48% reduction in ECGs and a 35% reduction in Holter monitors, thereby demonstrating that FibriCheck can be integrated seamlessly into existing workflows, which saves time, resources, and relieves pressure on workforces (Link to publication).